Suppr超能文献

[胰岛素依赖型糖尿病患者骨密度及骨转换相关指标的评估]

[The evaluation of bone mineral density and selected markers of bone turnover in patients with insulin dependent diabetes mellitus].

作者信息

Miazgowski T, Andrysiak-Mamos E, Pynka S, Gulińska M, Czekalski S

机构信息

Kliniki Endokrynologii, Nadciśnienia Tetniczego i Chorób Przemiany Materii.

出版信息

Przegl Lek. 1997;54(7-8):533-9.

PMID:9480464
Abstract

The aim of study was to evaluate bone mineral density (BMD) in lumbar spine (AP Spine), total body (Total Body) and distal site of radius (Forearm), and selected markers of bone formation: serum alkaline phosphatase (ALP) and osteocalcin(OC), and bone resorption: pyridinoline (PIR) and deoxy-pyridinoline (DPIR) in urine, in patients with long-standing insulin-dependent diabetes mellitus (IDDM), in comparison to healthy controls. Additionally, the influence of age, sex, smoking, duration of IDDM, the degree of metabolic control, or coexisting chronic complications of diabetes (retinopathy, incipient nephropathy, polyneuropathy) on the studied indices of bone metabolism in patients with IDDM were evaluated. The study was carried on 54 diabetic patients (23 F, 31 M) and 25 healthy individuals (13 F, 12 M). BMD was measured by DEXA (LUNAR DPX-L System). ALP was assessed by enzymatic method, and OC by RIA (Incstar Corporation). PIR and DPIR were assessed by EIA (Metra Biosystems). It was found that patients with long-standing IDDM have significantly lower BMD than healthy controls. The incidence rate of osteopenia and osteoporosis is significantly higher in this group of patients in comparison to the controls. In comparison to healthy subjects, patients with IDDM have significantly higher, but within normal reference range, serum ALP and OC, accompanied by similar PIR and not significantly increased DPIR. Duration and metabolic control of diabetes, or the coexistence of its chronic complications do not correlate with BMD or the studied indicies of bone turnover.

摘要

本研究旨在评估长期胰岛素依赖型糖尿病(IDDM)患者腰椎(前后位脊柱)、全身和桡骨远端(前臂)的骨矿物质密度(BMD),以及骨形成的选定标志物:血清碱性磷酸酶(ALP)和骨钙素(OC),和骨吸收标志物:尿中的吡啶啉(PIR)和脱氧吡啶啉(DPIR),并与健康对照组进行比较。此外,还评估了年龄、性别、吸烟、IDDM病程、代谢控制程度或糖尿病并存的慢性并发症(视网膜病变、早期肾病、多发性神经病变)对IDDM患者骨代谢研究指标的影响。该研究纳入了54例糖尿病患者(23例女性,31例男性)和25例健康个体(13例女性,12例男性)。通过双能X线吸收法(DEXA,LUNAR DPX-L系统)测量BMD。采用酶法评估ALP,采用放射免疫分析法(Incstar公司)评估OC。采用酶免疫分析法(Metra Biosystems)评估PIR和DPIR。研究发现,长期IDDM患者的BMD显著低于健康对照组。与对照组相比,该组患者骨质疏松症和骨质疏松的发生率显著更高。与健康受试者相比,IDDM患者的血清ALP和OC显著升高,但在正常参考范围内,同时伴有相似的PIR且DPIR无显著升高。糖尿病的病程和代谢控制,或其慢性并发症的并存与BMD或骨转换研究指标无关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验